Latest News & Features
Americas
Fustibal, a targeted therapeutics biotechnology start-up, has filed an inter partes review petition challenging a patent owned by German pharmaceutical company Bayer. 4 August 2016
Americas
Editas Medicine, a US genome-editing company, announced yesterday that it has entered into an exclusive licensing agreement with Massachusetts General Hospital to access CRISPR technology. 4 August 2016
Americas
Natco Pharma, an India-based drugs company, announced today that it has received final approval from the US Food and Drug Administration to produce a generic version of Tamiflu. 4 August 2016
Americas
Inter-partes reviews (IPRs) can be a powerful weapon against patents listed in the Orange Book. However, IPR practice favours a petitioner who has carefully thought about the issues and crafted the best strategy, says Mark Remus of Brinks Gilson & Lione. 4 August 2016
Americas
Pfizer has acquired Bamboo Therapeutics, a biotechnology company based in North Carolina. 3 August 2016
Americas
Teva’s acquisition of Allergan’s generic business has been completed, the company revealed yesterday. 3 August 2016
Big Pharma
The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV. 2 August 2016
Europe
The English High Court has referred two questions on supplementary protection certificates to the Court of Justice of the European Union in a case between Merck Sharp & Dohme and the UK Intellectual Property Office. 2 August 2016
Americas
Law firm Akerman has hired Thomas Pasternak in the intellectual property practice group in Chicago. 2 August 2016
Americas
The Brazilian Federal Prosecutor’s Office has taken court action against Roche for allegedly abusing IP rights in its sales of Herceptin to state governments. Anderson Ribeiro and Ricardo Campello of Provedel Advogados analyse the case. 2 August 2016